Citius Pharmaceuticals Inc Sustainability Reports
Citius Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of first-in-class critical care products. The company's pipeline includes anti-infectives, adjunct cancer care, oncology therapies, and stem cell treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493005C10W36P4KQP40
FIGI: BBG001V1J7S4
9 reports from 2014 to 2024
